$2.89
0.093.21%
At close: -
$2.90
0.010000.35%
After Hours: Dec 27, 9:27 AM EDT
Comments
Loading...
CytoMed Therapeutics (GDTC) Forecast
NewsEarningsCytoMed Therapeutics (GDTC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCytoMed Therapeutics (NASDAQ:GDTC) Stock Quotes, Forecast and News Summary
CytoMed Therapeutics Stock (NASDAQ: GDTC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy CytoMed Therapeutics (GDTC) stock?
You can purchase shares of CytoMed Therapeutics (NASDAQ:GDTC) through any online brokerage.
Who are CytoMed Therapeutics (GDTC) competitors?
Other companies in CytoMed Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), OncoCyte (NASDAQ:OCX), Intensity Therapeutics (NASDAQ:INTS), Curis (NASDAQ:CRIS) and Palatin Techs (AMEX:PTN).
What is the forecast, or price target, for CytoMed Therapeutics (GDTC) stock?
CytoMed Therapeutics has a consensus price target of $5.00.
What is the current price for CytoMed Therapeutics (GDTC)?
The stock price for CytoMed Therapeutics (NASDAQ: GDTC) is $2.9 last updated December 27, 2024 at 9:27 AM EST.
Does CytoMed Therapeutics (GDTC) pay a dividend?
There are no upcoming dividends for CytoMed Therapeutics.
When is CytoMed Therapeutics (NASDAQ:GDTC) reporting earnings?
CytoMed Therapeutics does not have any upcoming earnings scheduled.
Is CytoMed Therapeutics (GDTC) going to split?
There is no upcoming split for CytoMed Therapeutics.
What sector and industry does CytoMed Therapeutics (GDTC) operate in?
CytoMed Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.